|
2024
|
Invention
|
Substituted benzofuran propyl amine modulators of monoaminergic transporters.
Provided herein ar... |
|
|
Invention
|
Compositions and methods for increasing exposure of r(-)-mda.
Compositions and kits comprising e... |
|
|
Invention
|
Substituted benzofuran propyl amine modulators of monoaminergic transporters. 12345677, and X are... |
|
|
Invention
|
Compositions and methods for increasing exposure of r(-)-mda. Compositions and kits comprising en... |
|
|
Invention
|
Production of monoterpene indole alkaloid compounds in a heterologous host. Provided are non-natu... |
|
2023
|
Invention
|
N,n-dimethyltryptamine and methods of using the same. N,NN,N N,N-e.g.e.g., in the treatment of me... |
|
|
Invention
|
Use of mdma for treatment of stress-related disorders. Methods of treating a stress-related disea... |
|
|
Invention
|
Heteroatom substituted cyclic and alkyl amines as activators of serotonin receptors. The present ... |
|
2022
|
Invention
|
Dimethyltryptamine analogues as nitric oxide delivery drugs. Provided herein are compounds of For... |
|
|
Invention
|
Nitric oxide releasing prodrugs of mda and mdma. 12345677 and A are defined herein. Also provided... |
|
|
Invention
|
Aminotetraline activators of serotonin receptors. Provided herein are compounds of Formula (I), (... |
|
|
Invention
|
Novel prodrugs of mdma, mda, and derivatives thereof. The present disclosure provides prodrug com... |
|
|
Invention
|
Compositions and methods for treating headaches. The present disclosure provides new methods of t... |
|
|
Invention
|
Enantiomeric ratios of 3,4-methylenedioxymethamphetamine and related metabolites and uses thereof... |
|
|
Invention
|
Quick-release headset for presenting information using virtual reality and/or augmented reality, ... |
|
|
Invention
|
Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomer... |
|
|
Invention
|
Ibogaine combination treatment.
The present disclosure is directed to methods of improving the t... |
|
|
Invention
|
Ibogaine combination treatment. The present disclosure is directed to methods of improving the th... |
|
|
Invention
|
S)-mdma isomers. RSS)-3,4-methylenedioxymethamphetamine. |
|
|
Invention
|
Systems, devices, and methods for generating and manipulating objects in a virtual reality or mul... |
|
|
Invention
|
Prodrugs of acyl carnitines. 122 is alkyl or aryl; and X- is a pharmaceutically acceptable anion. |
|
|
Invention
|
Novel prodrugs and conjugates of dimethyltryptamine. 12345899, X, Y, Z, W, and m are defined here... |
|
|
Invention
|
Dimethoxyphenylalkylamine activators of serotonin receptors. 1234566, and n are defined herein. A... |
|
|
Invention
|
New n,n-dimethyltryptamine salts and crystalline salt forms.
This disclosure provides N,N-dimeth... |
|
|
Invention
|
New n,n-dimethyltryptamine salts and crystalline salt forms. This disclosure provides N,N-dimethy... |
|
|
P/S
|
Administration and management of research grants; charitable services, namely, organizing and dev... |
|
|
Invention
|
Systems, devices, and methods for event-based knowledge reasoning systems using active and passiv... |
|
|
Invention
|
Novel n,n-dimethyltryptamine compositions and methods. A composition including N,N-dimethyltrypta... |
|
2021
|
P/S
|
Downloadable computer software for monitoring and managing mental health and communicating mental... |
|
|
P/S
|
Dietary supplements and dietetic preparations, namely, dietetic food adapted for medical use and ... |
|
2018
|
P/S
|
Custom manufacturing of medicinal materials in the nature of artificial limbs; custom manufacture... |
|
|
P/S
|
Dietary supplements and dietetic preparations; hygienic
preparations and articles; dental prepar... |
|
|
P/S
|
Dietary supplements and dietetic preparations; Hygienic preparations and articles; Dental prepara... |
|
2014
|
P/S
|
Business analysis, research and information services; Commercial trading and consumer information... |
